70 / 114
70
Bibliografia
Ayo, C.
et al.,
2013. Genetic Susceptibility to Chagas Disease: An Overview about the
Infection and about the Association between Disease and the Immune Response Genes.
BioMed Research International.
Volume 2013,Article ID 284729
http://dx.doi.org/10.1155/2013/284729Basile,L.
et al
.,2011.Chagas disease in European countries:the challenge of a surveillance
system.
Eurosurveillance
,16(37), pp.1-10.
Chagas Disease EuropeWorking Group, informação pessoal, 2013.
Cook, G.C. & Zumla,A.I., 2009.
Manson’sTropical Diseases
22nd ed. Cook & Zumla, ed.,
China: Saunders Elsevier.
Comissão das Comunidades Europeias,2006.Directiva 2006/17/CE da Comissão.
Jornal
Oficial da União Europeia
, p.L 38/40.
Cortez, J.
et al
., 2012. Emerging and under-recognized Chagas cardiomyopathy in
non-endemic countries.World Journal of Cardiology, 4(7), pp.234-239.
Dias, E.
et al
., 1956. Chagas’ Disease; a Clinical, Epidemiologic, and Pathologic Study.
Circulation
, 14(6),pp.1035-60.
Ferrão,A., Silva, M.,Atouguia, J., Seixas, J., 2012. Estudo Piloto Sobre a Prevalência da
Doença de Chagas emGrávidas Latino-americanas em Portugal –Tese de Mestrado.Insti-
tuto de Higiene e MedicinaTropical.
Ferrão,A.,Silva,M.,Atouguia,J.,Seixas,J., Em preparação.Estudo Piloto Sobre a Preva-
lência da Doença de Chagas emGrávidas Latino-americanas em Portugal.
Flores-Chávez, M.
et al
., 2007. Diagnóstico de laboratorio de la enfermedad de Chagas
importada.
Enfermedades Infecciosas y Microbiología Clínica
, 25(Supl. 3), pp.29-37.
Flores-Chávez, M.
et al
., 2008. Fatal congenital Chagas’ disease in a non-endemic area: a
case report.
Cases Journal
, 1.
Flores-Chávez, M.
et al
., 2009. Comparación de técnicas serológicas convencionales y no
convencionales para el diagnóstico de la enfermedad de Chagas importada en España.
En-
fermedades Infecciosas y Microbiología Clínica
, 28(5), pp.284-93.
Fondation Merieux &World Health Organization, 2008.
Focus on NeglectedTropical Diseases:
Chagas Disease a Public HealthThreat in theAmericas & Beyond
,Veyrier du Lac.
Gascon,J.,Bern,C.& Pinazo,M.-J.,2009.Chagas disease in Spain,the United States and
other non-endemic countries.
Acta tropica
, 115(1-2), pp.22-27.
Generalitat de Catalunya - Departament de Salut, 2010.
Protocol de cribratge i diagnòstic de
malatia de Chagas en dones embarassades llatinoamericanes i en els seus nadons
, Barcelona.
Góis, P.,Marques, J.C. & Padilla, B., 2009. Segunda ou terceira vaga?As características da
imigração brasileira recente em Portugal.
Revista Migrações
, 5, pp.111-133.
Guerri-Guttenberg, R.A.
et al
., 2008. Chagas cardiomyopathy: Europe is not spared!
Eu-
ropean Heart Journal
, 29(21), pp.2587-2591.
Instituto Nacional de Estatística, 2010.
Revista de Estudos Demográficos
Instituto Nacional de
Estatística, ed., Lisboa.
Internet: http//www.berenice-project.eu/.Acedido em 9.10.2013.
Jackson,Yves
et al
., 2009. CongenitalTransmission of Chagas Disease in Latin American
Immigrants in Switzerland.
Emerging Infectious Diseases
, 15(4), pp.601-603.
Junior,A.R.,Rassi,S.G.& Rassi,A.,2001.Sudden death in Chagas’disease.
Arquivos Brasi-
leiros de Cardiologia
, 76(1), pp.86-96.
Laranja,Francisco S.,Dias,Emmanuel &Nobrega,Genrad,1948.Clínica e terapêutica da
doença de Chagas.
Memórias do Instituto Oswaldo Cruz
, 46(2), pp.473-529.
Maudlin, I., Holmes, P.H. & Miles, Michael A., 2004.
TheTrypanosomiases
, 1st ed. CABI
Publishing. ed.,Trowbridge: Cromwell Press.
Marin-Neto, J.Antonio
et al
., 2009.The BENEFIT trial: testing the hypothesis that trypa-
nocidal therapy is beneficial for patients with chronic Chagas heart disease.
Memórias do
Instituto Oswaldo Cruz
, 104(June Suppl. I), pp.319-324.
Molina, I.
et al.,
2012. Evaluación de Posaconazol como nuevo agente contra la enferme-
dad de Chagas.
VIII taller sobre la enfermedad de Chagas importada
,Avances en el tratamiento
antiparasitario, pp.21-22.
Nisida, I.V.
et al
., 1999.A Survey of Congenital Chagas’ Disease, carried out atThree He-
alth Institutions in São Paulo City, Brazil.
Revista do Instituto de MedicinaTropical de São Paulo
,
41(5), pp.305-311.
Otani, M.M.
et al
., 2009.WHO comparative evaluation of serologic assays for Chagas
disease.
Transfusion
, 49(6), pp.1076-1082.
Pérez-Molina, J.A.
et al
., 2009. Use of benznidazole to treat chronic Chagas’ disease: a
systematic review with a meta-analysis.
The Journal of Antimicrobial Chemotherapy
, 64(6),
pp.1139-47.
Piron,M.
et al
.,2008.Seroprevalence of
Trypanosoma cruzi
infection in at-risk blood donors
in Catalonia (Spain).
Transfusion
, 48(9), pp.1862-1868.
Queirós, L.,
et al
. 2010. Estudo Epidemiológico da Doença de Chagas em Dadores de
Sangue.
AB0,
41, pp.29-34.
Rassi,A. &Marin-Neto, JoséAntonio, 2010. Chagas disease.
Lancet
, 375(9723), pp.1388-
1402.
Reiche, E.M.V.
et al
., 1996. Doença de Chagas congênita : epidemiologia , diagnóstico
laboratorial , prognóstico e tratamento.
Jornal de Pediatria
, 72(3), pp.125-132.
Rueda,A.B.
et al
.,2009.
Enfermedad de Chagas Importada.Protocolo deActuación en la Comunitat
Valenciana
GeneralitatValenciana - Conselleria de Sanitat, ed.,Valencia.
Serviço de Estrangeiros e Fronteiras,2012.
Relatório de Imigração Fronteiras eAsilo
,Oeiras.
Shikanai-Yasuda & Carvalho 2012. Oral Transmission of Chagas Disease.
Emerging Infec-
tions
, 2012:74, pp.845-852.
Sicuri, E.
et al
., 2011. Economic evaluation of Chagas disease screening of pregnant La-
tin American women and of their infants in a non endemic area.
Acta tropica
, 95 118(2),
pp.110-117.
Torrico, F., 2011. Rationale and design of a proof-of-concept phase II clinical study of
E1224, a new drug candidate for chronic Chagas disease.
Tropical Medicine & International
Health
, 16(Supp. I), pp.21-22.
Velarde-Rodríguez, M.
et al
., 2009. Need for comprehensive health care for
Trypanoso-
ma cruzi
infected immigrants in Europe.
Revista da Sociedade Brasileira de MedicinaTropical
,
42(Sup. II).
Villar JC,Villar LA,Marin-Neto JA, Ebrahim S,Yusuf S.Trypanocidal drugs for chronic
asymptomatic
Trypanosoma cruzi
infection.
Cochrane Database of Systematic Reviews
2002,Issue
1.Art. No.: CD003463. DOI: 10.1002/14651858.CD003463.
Viotti, R.
et al
., 2011. Impact of aetiological treatment on conventional and multiplex
serology in chronic Chagas disease.
PLoS neglected tropical diseases
, 5(9), p.e1314.
Wilson, L.S.
et al
., 2008. Cost-effectiveness of implementation methods for ELISA sero-
logy testing of
Trypanosoma cruzi
in California blood banks.
The American Journal ofTropical
Medicine and Hygiene
, 79(1), pp.53-68.
WHO Expert Committee, 2002.
Control of Chagas Disease
, Genebra.
World Health Organization, 2007.
Reporte sobre la enfermedad de Chagas
, BuenosAires.
World Health Organization, 2008.
Chagas disease :control and elimination Report of the Secre-
tariat
, Genebra.
World Health Organization, 2009b.
Control and prevention of Chagas disease in Europe
, Ge-
nebra.
World Health Organization, 2010.
Chagas disease :control and elimination
, Genebra.
World Health Organization, 2011.
Working to overcome the global impact of neglected tropical
diseases
, Genebra.
Artigo Original